Teva Partners with Fosun Pharma to Advance Novel Cancer Immunotherapy TEV-56278
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.
Posts Tagged ‘NYSE:TEVA’
Teva’s Ajovy Shows Sustained Long-Term Efficacy in Migraine Prevention Trial
Teva Pharmaceutical (NYSE:TEVA) is one of the most undervalued large cap stocks to buy according to analysts.
16 Most Promising Stocks According to Wall Street Analysts
On July 3, Scott Wren, Wells Fargo senior global market strategist, and Adam Crisafulli, Vital Knowledge founder, joined 'Closing Bell Overtime' on CNBC to talk about the current...
13 Most Undervalued Large Cap Stocks to Buy According to Analysts
On July 3, Ben Preston, Portfolio Manager at Orbis Investments, appeared on CNBC to suggest that investors look past the constant political headlines and market volatility and...
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra.
Goldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug Growth
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
Billionaire Stan Druckenmiller’s 10 Stock Picks with Huge Upside Potential
Stanley Druckenmiller, an American billionaire investor, is the founder of Duquesne Capital.
Teva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych Congress
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has unveiled new data at the 2025 Psych Congress Elevate, highlighting significant advances in schizophrenia treatment.
Teva Pharmaceutical Industries Limited (TEVA) Study Finds Gaps in Tardive Dyskinesia Care at Long-Term Facilities
A new study from Teva Pharmaceutical Industries Limited (NYSE:TEVA) has uncovered alarming gaps in the diagnosis and treatment of tardive dyskinesia (TD) among residents in long...
Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target
Teva Pharma is an Israeli pharmaceutical company best known as one of the world’s largest manufacturers of generic drugs.
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408
Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced today that its investigational drug TEV-53408 has received Fast Track designation from the US Food and Drug Administration...
Regulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)
Sound Shore Management, an investment management firm, has released its investor letter for the first quarter of 2025. A copy of the letter can be downloaded here.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
10 Best Affordable Stocks Under $20 to Buy
On May 6, Paul Tudor Jones, Tudor Investment Corporation founder and CIO, and Robin Hood Foundation founder and board member, appeared on CNBC’s ‘Squawk Box’ to talk about...
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
Billionaire Larry Robbins’ 10 Stock Picks with Huge Upside Potential
Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2025 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2025 Earnings Call Transcript May 7, 2025Teva Pharmaceutical Industries Limited beats earnings expectations.
Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
8 Most Undervalued Healthcare Stocks to Buy According to Analysts
Healthcare prices and expenditures have been rising in the United States.
Was Jim Cramer Right About These 23 Stocks?
In this article, we will take a look at 23 stocks that Jim Cramer discussed 12 months ago during his show on March 22, 2024, and examine whether he was right or wrong about those...
10 Best Weight Loss Drug Stocks to Buy According to Analysts
Most people have tried to include fitness and weight loss into their everyday routines.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools...
Top 12 Stocks to Buy According to Bourgeon Capital
Bourgeon Capital Management LLC is an investment advisory firm headquartered in Darien, Connecticut.
Is Teva Pharmaceutical (TEVA) Trading at a Discount?
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A copy of the letter can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Call Transcript January 29, 2025Teva Pharmaceutical Industries Limited beats earnings expectations.
12 Best Middle East and Africa Stocks To Buy Right Now
Global financial giants are increasingly turning their attention to the Middle East and are establishing operations in cities such as Dubai, Abu Dhabi, and Riyadh.
10 Firms Kick Off 2025 Trading in The Red
Share prices of Aurora Innovation dropped for a fourth consecutive day on Thursday as investors continued to sell off positions over concerns that the US electric vehicle (EV) ...
10 Biggest Gainers of Last Week
Investors gobbled up shares of predominantly technology companies last week, following announcements of multi-billion dollars of investments, quantum technology backing, and new...
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
Jim Cramer Just Discussed These 13 Stocks
As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is wondering what 2025 will hold for markets.
12 Best Stocks Under $25 To Invest In Right Now
In this article, we will navigate through the US stock market alongside respective sectors after the elections while discussing the 12 best stocks under $25 to invest in right...
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript November 6, 2024Teva Pharmaceutical Industries Limited misses on earnings expectations.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra.
8 Best Stocks Under $50 To Invest In Now
As we navigate through 2024, the economic landscape presents a mix of challenges and opportunities for investors.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript July 31, 2024Teva Pharmaceutical Industries Limited beats earnings expectations.
10 Best Robinhood Stocks Under $20
The market reacted favorably after the Federal Reserve’s June 11-12 meeting. The broader market marked record closes.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3
Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2023. A copy of the same can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
13 Most Undervalued Pharma Stocks To Buy According To Analysts
In this piece, we will take a look at the 13 most undervalued pharmaceutical stocks to buy according to analysts.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Q2 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I'll be coordinating the call today.
5 Best Medical Stocks Under $10
In this piece, we will take a look at the five best medical stocks under $10.
Analysts are Upgrading These 10 Stocks
In this article, we will take a look at the 10 stocks recently upgraded by analysts.
15 Stocks Warren Buffett Sold
Berkshire Hathaway, headed by Warren Buffett, sold $13.3 billion worth of stock in the first quarter of 2023 while investing only a fraction of that amount in US equities.
